Today’s AI Top Pick: G

Genpact (G) is the cleanest quality-trend setup in the pool right now. It hits every box on the checklist: bullish_prob = 1.0, near_term_bullish = 1.0, and all four timeframes agree — 1h fc_long +14.5%, 4h fc_mid +18.3%/long +31.8%, 1d fc_short +17.2%/mid +29.7%/long +34.4%, and 1wk fc_mid +31.7%/long +40.8%. Critically, unlike PTC, MANH, or DOX, this alignment is NOT paired with an extended chart — the 1wk position in range is 9.15% (near the bottom) with a -28.64% drawdown from the 21-bar high, and 1d position is 42.5% (mid-range). You are buying the pullback, not chasing the top. Fundamentals are the best-in-lens combination of value and quality here: fwdPe 6.56, PEG 0.55 (the lowest PEG among the whole slate), ROE 23.1%, profit margin 11.0%, debt/equity 0.71, salesYoY +6.5%, and analyst targetUpsidePct 39.6%. Compare that to DOX (salesYoY -2.7% and AI-headwind headlines), TCOM (Citi target cut + China Renaissance downgrade to Hold), or PTC (analysts split on AI growth and pos_in_21bar_range at 100% on 3 of 4 timeframes — you'd be buying the exact high). The news tape supports the pick rather than undercutting it: TD Cowen reiterated Buy (lowered PT modestly to $42, still ~43% upside from $29.44), Genpact announced a new Global Capability Center partnership with Nestlé Business Solutions (2026-07-09) — a concrete revenue catalyst — and there are no material overhangs (no guidance cut, no legal issues, no short-seller report). Short float is elevated at 10.9%, which if anything sets up a squeeze on a positive move. Why TODAY vs. waiting: G is sitting close to its 21-bar low with a -28.6% weekly drawdown, models forecasting a 30%+ mean-reversion move over the next 1-3 months, positive analyst catalyst just 4 days old, and a P/E under 10. Waiting for further weakness risks missing the reversion; the 1h chart already shows the base forming (pos 69% in 21bar range with mildly positive 1h forecasts).